首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1085375

糖尿病设备、治疗药的与全球市场:各类别(诊断监测，治疗)，各疾病类型，各地区-规模，占有率，展望，机会分析(2022年～2028年)

Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月29日 | 出版商:

Coherent Market Insights | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

简介目录

新兴国家的糖尿病诊断、治疗相关认知度低，预计阻碍糖尿病设备、治疗药市场成长。

本报告提供全球糖尿病设备、治疗药市场的相关调查，市场展望，市场动态，市场分析，竞争情形等全面性资讯。

简介
- 市场占有率分析(%)(2022年～2028年)
- 与前一年同期比较成长分析(2017年～2028年)
- 市场区隔趋势
诊断和监测
- 简介
- 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
- 市场区隔趋势
血糖监测系统设备
其他的实验设备
糖尿病监测的软体程序
人工胰臟
治疗
- 简介
- 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
- 市场区隔趋势
胰岛素
胰岛素通知
口服血糖降落药
细胞治疗

第5章全球糖尿病设备、治疗药市场:各疾病类型(100万美元)(2017年～2028年)

简介
- 市场占有率分析(%)(2022年～2028年)
- 与前一年同期比较成长分析(2017年～2028年)
- 市场区隔趋势
第二型糖尿病
- 简介
- 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
- 市场区隔趋势
第一型糖尿病
- 简介
- 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
- 市场区隔趋势

第6章全球糖尿病设备、治疗药市场:各地区(100万美元)(2017年～2028年)

简介
- 市场占有率分析(%)(2022年～2028年)
- 与前一年同期比较成长分析(2017年～2028年)
- 市场区隔趋势
北美
美国
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
其他的欧洲
亚太地区
中国
印度
日本
东南亚国协
澳洲
韩国
其他的亚太地区
南美
巴西
墨西哥
阿根廷
其他的南美
中东
GCC各国
以色列
其他的中东
非洲
北非
中非
南非

第7章竞争情形

企业简介

Abbott Laboratories
Bristol-Myers Squibb
DexCom, Inc.
Eli Lilly and Company
Companion Medical
GlaxoSmithKline plc
Glenmark Pharmaceuticals
Johnson &Johnson
Lupin Ltd.
F. Hoffmann-La Roche AG
Sanofi

第8章 Section

参考文件
调查手法
关于本公司与营业窗口

简介目录

Product Code: CMI3857

Diabetes devices and drugs (diagnosis, monitoring and therapeutics) consists of diabetes management right from diagnosis, monitoring, till treatment. Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests used in the diagnosis of the chronic condition. Treatment options include use of insulin, oral hypoglycemic agents, and others.

Restraints of the Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market

Lack of awareness about diabetes diagnostics and treatment, especially in emerging economies, is expected to hinder growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. Moreover, recall of diabetes drugs is also expected to limit growth of the market.

Key features of the study:

This report provides in-depth analysis of the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category:
- Diagnosis and Monitoring
Blood Glucose Monitoring Devices
Other Testing Devices
Software Programs for Diabetes Monitoring
Artificial Pancreas
- Therapeutics
Insulin
Insulin Delivery
Oral Hypoglycemic Agents
Cell Therapies
Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type:
- Type 2 Diabetes
- Type 1 Diabetes
Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Geography:
- North America
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- U.S.
- Canada
- Europe
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country/Region:
- Central Africa
- South Africa
- North Africa
Company Profiles
- Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
- Bristol-Myers Squibb
- DexCom, Inc.
- Eli Lilly and Company
- Companion Medical
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals
- Johnson & Johnson
- Lupin Ltd.
- F. Hoffmann-La Roche AG
- Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description

Market Definition and Scope
- Executive Summary
Market Snippet, By Category
Market Snippet, By Disease Type
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis

4. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Diagnosis and Monitoring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Blood Glucose Monitoring Devices
- Other Testing Devices
- Software Programs for Diabetes Monitoring
- Artificial Pancreas
- Therapeutics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Insulin
- Insulin Delivery
- Oral Hypoglycemic Agents
- Cell Therapies

5. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Type 2 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Type 1 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends

6. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Regions, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles

Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DexCom, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Companion Medical
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glenmark Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lupin Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies